<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2024-11137">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2024_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2024-05-21</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Schedules of Controlled Substances: Rescheduling of Marijuana</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2024-05-21/html/2024-11137.htm">
        <identifier type="FDsys Unique ID">D09002ee1c72ca943</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2024-05-21/pdf/2024-11137.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c72ca9d7</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Justice</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Drug Enforcement Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Department of Justice ("DOJ") proposes to transfer marijuana from schedule I of the Controlled Substances Act ("CSA") to schedule III of the CSA, consistent with the view of the Department of Health and Human Services ("HHS") that marijuana has a currently accepted medical use as well as HHS's views about marijuana's abuse potential and level of physical or psychological dependence. The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing. If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations. If marijuana is transferred into schedule III, the manufacture, distribution, dispensing, and possession of marijuana would remain subject to the applicable criminal prohibitions of the CSA. Any drugs containing a substance within the CSA's definition of "marijuana" would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act ("FDCA"). DOJ is soliciting comments on this proposal.</abstract>
    <identifier type="FR citation">89 FR 44597</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2024-05-21/2024-11137</identifier>
    <identifier type="FR Doc No.">2024-11137</identifier>
    <identifier type="former granule identifier">fr21my24-13</identifier>
    <identifier type="billing code">4410-09-P</identifier>
    <identifier type="department code">Docket No. DEA-1362</identifier>
    <identifier type="department code">A.G. Order No. 5931-2024</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2024-05-21/2024-11137</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2024-05-21/html/2024-11137.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2024-05-21/pdf/2024-11137.pdf</url>
    </location>
    <subject>
        <topic>Administrative Practice and Procedure</topic>
        <topic>Drug Traffic Control</topic>
        <topic>Reporting and Recordkeeping Requirements</topic>
    </subject>
    <physicalDescription>
        <extent>26 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>44597</start>
            <end>44622</end>
        </extent>
    </part>
    <identifier type="preferred citation">89 FR 44597</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1308</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1308</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Schedules of Controlled Substances: Rescheduling of Marijuana; Federal Register Vol. 89, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>2024-11137</accessId>
        <agency order="1">DEPARTMENT OF JUSTICE</agency>
        <agency order="2">Drug Enforcement Administration</agency>
        <commentDate>2024-07-22</commentDate>
        <publicMeetingDate>2024-06-20</publicMeetingDate>
        <departmentDoc>Docket No. DEA-1362</departmentDoc>
        <departmentDoc>A.G. Order No. 5931-2024</departmentDoc>
        <billingCode>4410-09-P</billingCode>
        <frDocNumber>2024-11137</frDocNumber>
        <action>Notice of proposed rulemaking.</action>
        <summary>The Department of Justice ("DOJ") proposes to transfer marijuana from schedule I of the Controlled Substances Act ("CSA") to schedule III of the CSA, consistent with the view of the Department of Health and Human Services ("HHS") that marijuana has a currently accepted medical use as well as HHS's views about marijuana's abuse potential and level of physical or psychological dependence. The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing. If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations. If marijuana is transferred into schedule III, the manufacture, distribution, dispensing, and possession of marijuana would remain subject to the applicable criminal prohibitions of the CSA. Any drugs containing a substance within the CSA's definition of "marijuana" would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act ("FDCA"). DOJ is soliciting comments on this proposal.</summary>
        <dates>Comments must be submitted electronically or postmarked on or before July 22, 2024. Interested persons may file a request for a hearing or waiver of an opportunity for a hearing or to participate in a hearing pursuant to 21 CFR 1308.44 and in accordance with 21 CFR 1316.47 or 1316.49, as applicable, which must be received or postmarked on or before June 20, 2024.</dates>
        <contact>Drug &amp; Chemical Evaluation Section, Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-3249; Email: nprm@dea.gov.</contact>
        <cfr title="21">
                                    
            <part number="1308"/>
                                    
            <subject>Administrative Practice and Procedure</subject>
                                    
            <subject>Drug Traffic Control</subject>
                                    
            <subject>Reporting and Recordkeeping Requirements</subject>
                                
        </cfr>
        <tocSubject1>Schedules of Controlled Substances:
</tocSubject1>
        <tocDoc>Rescheduling of Marijuana, </tocDoc>
        <emailRef>nprm@dea.gov</emailRef>
        <urlRef>https://iris.who.int/bitstream/handle/10665/251056/9789241510240-eng.pdf</urlRef>
        <urlRef>https://monitoringthefuture.org/wp-content/uploads/2022/12/mtf2022.pdf</urlRef>
        <urlRef>https://nap.nationalacademies.org/read/24625/chapter/1</urlRef>
        <urlRef>https://nida.nih.gov/news-events/news-releases/2022/08/marijuana-and-hallucinogen-use-among-young-adults-reached-all-time-high-in-2021</urlRef>
        <urlRef>https://nida.nih.gov/research/research-data-measures-resources/cannabis-potency-data</urlRef>
        <urlRef>https://store.samhsa.gov/sites/default/files/pep23-07-03-001.pdf</urlRef>
        <urlRef>https://www.dea.gov/operations/eradication-program</urlRef>
        <urlRef>https://www.deadiversion.usdoj.gov/GDP/</urlRef>
        <urlRef>https://www.mpp.org/issues/medical-marijuana/state-by-state-medical-marijuana-laws/medical-marijuana-patient-numbers</urlRef>
        <urlRef>https://www.regulations.gov</urlRef>
        <urlRef>https://www.rmhidta.org/_files/ugd/4a67c3_b391ac360f974a8bbf868d2e3e25df3d.pdf</urlRef>
        <urlRef>https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.pdf</urlRef>
        <urlRef>https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf</urlRef>
        <urlRef>https://www.samhsa.gov/data/sites/default/files/reports/rpt42731/2022-nsduh-nnr.pdf</urlRef>
        <urlRef>https://www.samhsa.gov/data/sites/default/files/reports/rpt42794/2021-teds-annual-report.pdf</urlRef>
        <urlRef>https://www.usp.org/200-anniversary/usp-timeline</urlRef>
        <urlRef>https://www.whitehouse.gov/briefing-room/statements-releases/2022/10/06/statement-from-president-biden-on-marijuana-reform/</urlRef>
        <urlRef>https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee1c72c96b1" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2024-05-21/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 89, no. 99</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2024-05-21</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>364 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2024-05-21">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2024-05-21</identifier>
        <identifier type="local">P0b002ee1c72c96b1</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr21my24</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2024-05-21</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2024-05-21/pdf/FR-2024-05-21.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2024-05-21/xml/FR-2024-05-21.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>44545</start>
                <end>44899</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2024-05-21</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-05-21</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2024-05-21</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2024-05-21</accessId>
            <volume>89</volume>
            <issue>99</issue>
        </extension>
    </relatedItem>
</mods>
